21 research outputs found
Substandard and falsified cosmetic identification scores by education level.
Substandard and falsified cosmetic identification scores by education level.</p
Content validity ratio and factor structure emerging from principle factor analysis.
Content validity ratio and factor structure emerging from principle factor analysis.</p
Reliability assessment criteria of the study scale (n = 1280).
Reliability assessment criteria of the study scale (n = 1280).</p
Scree plot and component factors resulting from the PCA.
Scree plot and component factors resulting from the PCA.</p
Flow chart for development and validation process.
Flow chart for development and validation process.</p
sj-docx-1-end-10.1177_11795514241235514 – Supplemental material for Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study
Supplemental material, sj-docx-1-end-10.1177_11795514241235514 for Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study by Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Tariq Al-Qirim and Monzer Shahwan in Clinical Medicine Insights: Endocrinology and Diabetes</p
sj-docx-1-end-10.1177_11795514231203913 – Supplemental material for Insights Into Metformin XR Pharmacotherapy Knowledge Among Community Pharmacists: A Cross-Sectional Study
Supplemental material, sj-docx-1-end-10.1177_11795514231203913 for Insights Into Metformin XR Pharmacotherapy Knowledge Among Community Pharmacists: A Cross-Sectional Study by Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Nageeb Hassan, Sa’ed H Zyoud, Ammar Ali Saleh Jaber and Tariq Al-Qirim in Clinical Medicine Insights: Endocrinology and Diabetes</p
DataSheet1_Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis.PDF
Background: Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care.Methods: we used a cross-sectional design to assess the perceptions and practices of community pharmacists concerning pharmaceutical care for patients with CVD. A trained researcher visited randomly selected community pharmacies and used a structured questionnaire to conduct in-person interviews with pharmacists. The questionnaire collected demographic data and information on perceptions and practices regarding CVD pharmaceutical care.Results: Five hundred and fifty-one participants were recruited. The average participant age (mean ± SD) was 35 ± 2.7 years. The average perception score regarding CVD prevention and management was 75.6% (95% confidence interval [CI] 77.1%–74.2%), and the average practice score for CVD prevention and management was 87.1% (95% CI 76.5%–79.6%). Bivariate analysis revealed that gender (p = 0.001), education level (p 10 years of experience (OR 11.3; 95% CI 6.01–15.62), pharmacists with 6–10 years of experience (OR 4.42; 95% CI 3.90–5) and pharmacists trained on CVD prevention and management (OR 1.29; 95% CI 1.15–1.46).Conclusion: Pharmacy practitioners working in community pharmacies in the UAE actively engage in delivering pharmaceutical care to patients, playing a role in CVD management and prevention. However, they showed low levels of involvement in other healthcare services, specifically in screening and measuring patients’ weight, glucose levels, and blood pressure, monitoring treatment responses, maintaining medical records, and reviewing medication refill histories. Activities such as educating patients, providing medication counseling, offering support for treatment adherence, and fostering collaborative relationships with other healthcare providers should be encouraged among UAE community pharmacists to ensure the provision of high-quality patient care.</p
